Clinical Trial Update: Assessment of the Safety and Effectiveness of Cortical Stimulation in Subjects With Major Depressive Disorder [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety and effectiveness of cortical stimulation for major depressive disorder. The study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Northstar Neuroscience | Conditions: Depression, Depressive Disorder | Phase 1 | Status: TERMINATED